Switch from efavirenz to nevirapine associated with resolution of efavirenz-related neuropsychiatric adverse events and improvement in lipid profiles.

Abstract

In a large HIV-specialty private practice, patients with undetectable or low-grade-positive viral loads with neuropsychiatric side effects or elevated lipids were switched from efavirenz-to nevirapine-based antiretroviral regimens. This is a retrospective analysis of virologic efficacy and changes in adverse neuropsychiatric effects and serum lipid levels… (More)

Topics

Cite this paper

@article{Ward2006SwitchFE, title={Switch from efavirenz to nevirapine associated with resolution of efavirenz-related neuropsychiatric adverse events and improvement in lipid profiles.}, author={Douglas J. Ward and John M Curtin}, journal={AIDS patient care and STDs}, year={2006}, volume={20 8}, pages={542-8} }